Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.

The main elements of My Virbac are:

• Business support tools to help enhance business processes and overall productivity and profitability. This section includes access to a mystery shopping service and staff training, as well as business auditing service. In its entry-level form, this is provided as an online audit. It can be upgraded to involve a bespoke report from a business consultant on request
• Marketing support including Virbac's 'Comms Manager' which guides practices aiming to build their profile through PR and social media. The marketing support section also offers tools to enable practices to print promotional materials
• Client-facing tools to help vets build stronger, long-term relationships. This section includes a 'Total Compliance' toolkit and online client satisfaction training
• Resource Library containing webinars, technical and business related articles and a stock of educational articles for websites and client newsletters

Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.

"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."

To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.

The British Small Animal Association has responded to Defra's statement on compulsory microchipping.

The Association says it is an advocate of compulsory microchipping as the most effective way to permanently identify a dog - as long as owners maintain an up-to-date registration on the various databases. As such it broadly welcomes the recent Defra statement.

However, BSAVA points out that the statement has come before a full and considered consultation in terms of its implementation, and says it raises a number of questions for vets in practice:

• The Dogs Trust scheme is offering to supply practices with the microchips. Yet with an estimated 3 million or more dogs in the UK currently without microchips, will the profession be expected to bear the brunt of the cost of training and paying staff to carry out the procedure, as well as the significant administration that follows?
• The current information from Defra suggests that the service will be free to pet owners. Even if this is the case at the Dogs Trust, Battersea and Blue Cross centres, it is unlikely that they will receive all unchipped dogs, so will those owners entering a private practice have a similar expectation?
• BSAVA is also concerned about an emphasis on microchipping that doesn't also consider the management of the relevant databases. Implanting a microchip in itself is without value unless it is linked to accurate information that is kept up to date.

Despite the headlines around the statement, this is yet to be laid down in law and will require changes under the Animal Welfare Act and potentially the Dangerous Dogs Act, so there is still a conversation to be had about its implementation.

For this reason BSAVA has announced that it is launching a consultation with its members to establish their concerns and opinions in order to work with all the organisations involved in the best interest of animal welfare and the profession. If anyone in practice wants to feed into this consultation, they should visit http://www.bsava.com or contact BSAVA's Scientific Policy Officer Sally Everitt via email - s.everitt@bsava.com.

BSAVA President Mark Johnston said: "While implantation can be straightforward for those with appropriate experience it will be important to ensure that all those who carry out implantation are properly trained. However microchipping is not just a matter of implanting the microchip, there is a significant amount of administrative work in ensuring that animals are properly registered and that details are kept up-to-date. All of these stages need to be properly funded if the scheme is to be successful and sustainable. BSAVA will be consulting its members to gather their views and concerns and hope to be involved in a productive conversation with all interested parties."

BSAVA says there is a good news animal welfare story within this statement concerning the seizure of animals during investigation under the Dangerous Dogs Act. The new measures will allow the authorities to decide whether a suspected prohibited dog can stay with their owners until the outcome of court proceedings. Until now all such animals had to be kennelled until the proceedings had concluded, which often means that dogs who posed no risk suffered unnecessarily.  BSAVA welcomes this new measure in the interest of animal welfare.

Veterinary surgeons have named their top new veterinary products of 2012 in a survey carried out by CM Research.

As part of the research, 343 vets working in UK practice were asked what they considered to be the best new product of 2012. Their answers were unprompted, and they were only allowed to mention one product or service. For this reason, some vets voted for products that were launched earlier than 2012. The full results were as follows:

Hill's y/d
An iodine restrictive hyperthyroid management food launched by Hill's Pet Nutrition in May 2012 won with an overwhelming 31% of the votes. www.hillspet.co.uk

Cardalis (CEVA Animal Health)
Launched towards the end of 2012, CEVA's combined ACE inhibitor / spirolactone for heart failure in dogs scored a creditable 9.6% of mentions. www.ceva.co.uk

Seresto (Bayer Animal Health)
Bayer's 8-month flea and tick collar came third with 6% of the votes. www.seresto.com.

Caninsulin Vetpen from MSD
Launched in July 2012, this new insulin delivery pen for Caninsulin is designed to improving dosing accuracy, consistency and ease of use. The user-friendly pen design is said to improve initial pet owner acceptance and on-going compliance. 

Atopica Cat (Novartis Animal Health)
Novartis launched Atopica Cat, an oral version of its treatment for chronic allergic dermatitis, at the start of 2012. www.itchfreepet.co.uk

Comfortis (Elanco)
Launched in 2011, Comfortis is a novel oral flea adulticide for dogs which kills adult fleas rapidly for a month. www.comfortis.com

Nobivac Myxo RHD (MSD)
The first vaccine to combine 12 months protection against both myxomatosis and rabbit haemorrhagic disease within a single inoculation. It is a non-adjuvanted vaccine which, according to MSD, delivers greater simplicity of protocol and enhanced disease protection.

Cimalgex (Vétoquinol)
Launched towards the end of 2011, Vetoquinol's 2nd generation Cox-2 inhibitor is said by the company to be very well tolerated, have an excellent efficacy profile and be very easy to use, meaning that Cimalgex allows veterinary patients to benefit from pain relief in situations where clinicians would have been worried about the risks versus the benefits of prescribing a NSAID for pain management.

Activyl (MSD)
MSD's novel flea spot-on is the first to work by bioactivation, only becoming an insecticide after being ingested by the flea, thus minimising owner's exposure to insecticides. Said to be effective against the other stages of the flea life cycle, too. www.activyl.co.uk

RevitaCAM (Abbott)
RevitaCAM is the first and only veterinary NSAID (meloxicam) with oromucousal delivery. www.revitacam.co.uk.

Metacam for cats (Boehringer Ingelheim)
Boehringer extended its Metacam 0.5 mg/ml Oral Suspension for Cats range with the launch of a 30ml bottle size in July. www.metacam.co.uk.

Zuprevo (MSD)
MSD's antibiotic to combat bovine respiratory disease (BRD) was launched in the third quarter of 2011. www.zuprevo.com

V-Gel (Docsinnovent)
V-gel was the first ever species-specific supraglottic airway device (pictured top right), currently available for cats and rabbits. Billed as the latest ground breaking technology for a safer anaesthesia, easier breathing and avoiding damage to the throat and trachea; a safer alternative to ET tubes. www.docsinnovent.com

Onsior (Novartis Animal Health)
The tissue-selective oral and injectable Cox-2 inhibiting NSAID from Novartis was actually launched back in 2009.

Certifect (Merial)
Merial's flea and tick spot-on for dogs was launched by Ray Mears in the UK in February 2012. www.certifect.co.uk

Calmex (VetPlus)
Somewhat controversial when it made its first appearance in 2011, Calmex is a feed to help dogs and cats that may experience behavioural problems as a result of their environment or situations that may cause anxiety or fear. More info.

Comfortan (Dechra)
The first licensed methadone for dogs was launched by Eurovet towards the end of 2011, before it was acquired by Dechra in May 2012. www.dechra.co.uk

Hill's Vet Essentials
Hill's vet-exclusive petfood range is designed to meet essential dietary needs at every life stage. More info.

Trocoxil (Pfizer)
Trocoxil, Pfizer's NSAID for canine osteoarthritis was remarkable for its once monthly dosage regime, when launched back in 2009.

Veraflox
Bayer launched its next generation fluoroquinolone antimicrobial for bacterial infections in cats and dogs at the end of 2011.

Yumove
Yumove is a joint support supplement from Lintbells, containing glucosamine and chondroitin. More information.

The Advertising Standards Authority has decided not to uphold complaints against the Morrisons Christmas TV advertisement.

The full adjudication can be read here.

Peter Jones, President of the British Veterinary Association, said: "This ruling is disappointing but the ASA has set out its reasons for the decision and we accept those reasons. Thankfully, the advert only had a short shelf life and we hope that Morrisons is now very unlikely to make the same mistakes again. Overall, we hope the whole incident has served to educate Morrisons and the general public about the dangers of grapes and raisins to dogs."

Researchers from the School of Veterinary Sciences at the University of Bristol have had a study into domestic dogs' fear responses to noise published in Applied Animal Behaviour Science.

According to the University, the study provides an important insight into dogs' fear of noises, and could improve our understanding of behavioural signs of fear or anxiety.

In the study two approaches were taken to investigate the occurrence of, and risk factors for, behaviours caused by a fear of noise: a postal survey of dog owners to investigate general demographic factors and a structured interview of a sub-set of owners to gather more detailed information.

• Nearly 50% of owners reported that their dog showed at least one behavioural sign typical of fear when exposed to noises such as fireworks, thunder and gunshots
• Only 25% of the above reported their dog as 'fearful' of noises

It seems that while owners are often aware of their pet's behavioural response when exposed to a loud noise, they do not necessarily recognise it as being indicative of fear or anxiety. This has relevance both for awareness of compromised welfare, and the methodology for surveying such behaviour.

• The most commonly reported behavioural signs were vocalising, trembling/shaking, hiding, vocalising and seeking people, but researchers think trembling and shaking are more often reported than other behaviours because they are similar to fearful behaviours in humans

According to the researchers, other behavioural signs, such as decreased activity or salivation, may not be as easily recognised by owners as signs of fear, and may be under-reported. Also, signs of urination, salivation and destruction may make owners disappointed or angry, and this may influence their interpretation that such behaviours are associated with fearfulness.

• Responses to fireworks were the most common, but fear responses to loud noises such as fireworks, gunshots and thunder appear to commonly co-occur, suggesting generalisation between salient stimuli

The risk factors for owner-reported fear of noises included:

• Breed, although 12 breeds or breed types were less likely to show fear responses to noises than cross-breeds, including popular gundog breeds such as the Labrador, Cocker Spaniel and Springer Spaniel
• Age, where risk increased with age
• Origin, where dogs living with the owner who bred them had a reduced risk compared to dogs purchased from the breeder by a second owner, supporting the view that an early environment that is very similar to the environment experienced in adulthood  is advantageous

The researchers suggest a dog's early life experience is an important factor in the development of fear responses to specific loud noises.

Dr Rachel Casey, European Specialist in Veterinary Behavioural Medicine and Senior Lecturer in Companion Animal Behaviour and Welfare at Bristol University, said: "Our results suggest that the characteristics of dogs, their early environment, and exposure to specific loud noises are involved in the development of fear responses to noises. Interestingly, less than a third of owners sought professional advice about treatment for their pet's response to noises."

Disappointingly, less than a third of owners currently seek professional advice about treatment for their pet's fear. The researchers recommend there is a need for veterinary surgeons to increase awareness among the general dog owning public that treatment is both available and effective in dealing with fears of loud noises, and to direct them towards appropriate sources of help.

Information for vets and dog owners on finding an expert to help treat behaviour problems including fear of noises can be found at www.rspca.org.uk/findabehaviourist

Paper: Fear responses to noises in domestic dogs: Prevalence, risk factors and co-occurrence with other fear related behaviour, Emily J. Blackwell, John W.S. Bradshaw, Rachel A. Casey, Applied Animal Behaviour Science, published online 22 January 2013.

Ceva Animal Health has launched a new TV advertising campaign designed to raise awareness of problems owners may face in a multi-cat environment.

The Cat Cabin Fever campaign will run for four weeks.

Ceva says the 20 second TV ads have been designed to strike a chord with viewers who have more than one cat in their household, where 'sometimes sharing just isn't an option'. Highlighted in particular is the Feliway Diffuser which releases natural pheromones into a room to help cats feel at ease, allowing them to cope with stressful situations and prevent unwanted behaviour.  

Malcolm Laurie, head of marketing at Ceva, said: "We know that there are more than 8million cats in the UK and only 2.5million cat households, therefore the majority of households must have more than one cat.

"However, cats are solitary animals, which makes living with other cats difficult at times. This campaign is focused on making the lives of cat owners and their pets as harmonious as possible, including lots of top tips on how to ease any tensions in such an environment."

Ceva has also produced a multi-cat leaflet designed to give owners specific advice on how to provide the correct environment for our feline friends

The advertising campaign will be supported by online competitions, marketing materials for veterinary clinics and retailers, which include a checklist for a cat friendly home, and PR.

For more information, visit: http://www.feliway.co.uk/.

A new study¹ published in the Equine Veterinary Journal's (EVJ) special American Association of Equine Practitioners supplement has concluded that maggots can play an integral role in modern veterinary care for a variety of wounds in horses.

The study assessed the efficacy of maggot debridement therapy in a diversity of equine lesions and found that the method was beneficial in 93% of cases.

Maggots have been used for the treatment of wounds for hundreds of years. Freshly emerged, germ-free larvae of the common green bottle fly are usually used for the purpose. Their wound-healing action is attributed to a debridement effect, an antiseptic effect, a direct effect on cytokine and cell proliferation involved in wound healing and breakdown of biofilm formation. Maggots also destroy and digest bacteria and may also be beneficial in the fight against multi-drug-resistant bacteria such as MRSA.

The study involved the retrospective analysis of 41 horses with various lesions including foot injury, limb laceration, soft tissue abscesses and musculoskeletal infection. Depending on the type, size and location of the wound the maggots were applied either in direct or indirect contact. In some cases a second maggot application was necessary to reach the desired level of healing. Debridement, disinfection and healing occurred in all but three cases, in less than a week. Of the three that did not respond two were complicated by the presence of tumours and one by pre-existing damage to the underlying bone.

Olivier Lepage of the University of Lyon, who led the study, said: "These results show that maggot debridement therapy potentially has an integral place in modern veterinary wound care. It can be used to treat many types of lesions, although not those involving tumours or bone sequestration. Associated high costs present a limiting factor but maggot debridement therapy should certainly be considered for lesions that fail to respond to conventional methods."

Professor Celia Marr, Editor of the EVJ, said: "Horses often suffer from non-healing wounds, particularly in the limbs where the skin is under continuous movement and there is very little subcutaneous tissue. Although at first glance this study might seem counter-intuitive and we might think of maggots as being the last thing one would want on a clean wound, it shows that maggots can be an effective way to clear damaged tissue and this is an important adjunctive approach in equine wound management."

¹The use of maggot debridement therapy in 41 equids OM Lepage, A Doumbia, MF Perron-Lepage and M Gangl. EVJ ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2012.00609.x

The study is published by Wiley-Blackwell and can be accessed at http://onlinelibrary.wiley.com/doi/10.1111/j.2042-3306.2012.00609.x/abstract

Dr. Tracy Hill, a specialist in internal medicine, has joined the Royal (Dick) School of Veterinary Studies, bringing with her expertise in interventional radiology.

Tracy completed a fellowship in interventional radiology and endoscopy at the Animal Medical Centre in New York, will be researching new techniques in this developing field.

She will also work in the clinic at the School's Hospital for Small Animals and as a senior lecturer.

She said: "Interventional radiology is an emerging and expanding area in veterinary medicine. Interventional radiology employs the use of fluoroscopy and endoscopy to enable minimally invasive treatments for diseases in many body systems. These techniques often reduce morbidity, mortality, or cost associated with more invasive procedures. The Dick Vet has been performing interventional cardiac procedures for some time and we are looking to expand this field into treatment of non-cardiac diseases."

Tracy, who carried out her residency in small animal internal medicine at North Carolina State University, where she also completed a PhD, will help the Royal (Dick) School of Veterinary Studies at the University of Edinburgh to provide interventional radiology procedures.

This includes a minimally invasive treatment for certain liver shunts using a procedure only being regularly performed at a handful of veterinary hospitals in the world. In this procedure, fluoroscopic guidance is used to access the abnormal vessels in the abdomen via a catheter placed in the jugular vein in the neck. The abnormal shunt vessel is then closed using coil embolization, without the need for abdominal surgery.

Tracey said: "I am delighted to join the Dick Vet. There is no denying the expertise at the vet school, as well as its partnership with The Roslin Institute for research."

A study published by Mike Dryden - one of the world's leading parasitologists - in Veterinary Parasitology has demonstrated that spinosad (Comfortis, Elanco) provides a high level of flea control one month after a single treatment and maintains a high level of effectiveness under conditions of natural challenge following subsequent monthly treatments.

The multi-clinic, investigator-blinded study¹ was undertaken in client-owned dogs provided with three consecutive monthly treatments of oral spinosad (SPN) and fipronil/methoprene spot-on (FSM). All other household dogs and cats, to a maximum of four pets per household, were dispensed the same treatment. Subsequent treatments were given when the dog returned for whole-body flea counts and pruritus-scoring on days 30 and 60, with final assessments on day 90 (plus/minus five days on each occasion).

One hundred and twenty eight dogs were enrolled on the study at 10 veterinary practices in the USA (65 in the SPN arm and 63 in the FSM arm). On day 0, mean flea counts were 57.7 (range: 10-1469) and 44.8 (range: 10-717) for the SPN and FSM groups, respectively. On day 90, 55 of the 58 (95%) SPN dogs were flea free compared with only 21/55 or 38% of dogs in the FSM group. Mean pruritus scores declined to 0.92 (6.67 on day 0) in the SPN group and 3.83 (6.33 on day 0) in the FSM group by day 90. Mean flea counts were 0.08 and 5.19 for SPN and FSM groups respectively on day 90 correlating to a reduction in flea counts of 99.9% in the SPN dogs and 88.4% in the FSM dogs. Between treatment differences were found to be highly statistically significant (p<0.0001) for every parameter measured at every time point during the study in favour of SPN.

Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "The recent study confirms oral spinosad's outstanding efficacy in controlling fleas and associated pruritus in dogs when administered by owners following natural challenge in the home environment".

For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.

References

1       Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs.  Michael W. Dryden, William G. Ryan, Margie Bell, Anthony J. Rumschlag, Lisa M. Young, Daniel E. Snyder.  Veterinary Parasitology 191 (2013) 340-346

The Office of Fair Trading (OFT) has dropped the requirement that veterinary practices display a poster in waiting rooms which tells clients what the top ten medicines they supply are, and their costs.

The requirement was apparently dropped, initially for a six month period, following pressure from the Royal College, which felt says it felt the poster did not entirely serve its purpose.

The requirement for the poster was brought in following the Competition Commission investigation into veterinary medicine sales in 2005, as part of a range of measures. Some of the responsibilities were enforced via the RCVS as an alternative to legislation under the Fair Trading Act, to ensure that clients have access to sufficient information to be able to decide where to obtain veterinary prescriptions and medicines.

The poster, which was outlined in the Guide to Professional Conduct, and subsequently the Code of Professional Conduct, had to include information about prescriptions and repeat prescriptions, together with the 'ten relevant veterinary medicinal products most commonly prescribed during a recent and typical three-month period'.

How 'most commonly prescribed' has been calculated has often varied - for example, by price, volume, number of prescriptions, etc - and, in addition, different formulations, brands or pack sizes of the same active ingredient could cause confusion.

RCVS President, Jacqui Molyneux said: "Having seen how this has worked in practice, we have been keen to push for change because it was felt that the list could be confusing to clients.

"We have also been mindful of the fact that the ways in which consumers access information has changed radically over the last seven years or so, with internet searches becoming more prevalent.

"These factors conspired to make the list less meaningful as a tool that allowed consumers to shop around. It is thus hoped that the removal of the list will reduce potential misunderstanding among the public."

During the first six months following the change, the College and the OFT will monitor the situation. If there is no appreciable level of complaint from the public, the change will become permanent.

The other requirements of supporting guidance to the Code of Professional Conduct Chapter 10 (Fair Trading Requirements) remain unchanged (www.rcvs.org.uk/fairtrading), and the OFT recommends that the notice advising clients that they can obtain a prescription from the practice be made even more prominent.

In addition, it remains important that veterinary surgeons communicate medicines prices clearly to their clients and other callers, and that invoices itemise individual products supplied (www.rcvs.org.uk/medicines).

Pfizer has divested itself of its animal health business unit, which has become a stand-alone company called Zoetis. The new company unveiled its vision for Europe, Africa and the Middle East (EuAfME) region at a press conference in Paris last week.

The company says it aims to have its products, services and people as the most valued by animal health customers around the region, and the world.

Alejandro Bernal, Zoetis Executive Vice President and Area President for the EuAfME region said: "We are united around this shared vision, and we strive every day to help customers meet their real-world challenges through quality medicines and vaccines, complemented by diagnostic products, genetic tests and a range of services," said  "As the largest standalone company in the industry, we are dedicated solely to animal health and focusing on our core business so our customers can grow theirs."

In addition to working closely with customers, Zoetis said it strives to collaborate with universities and other research organisations, to help advance the animal health sector and those who raise and care for animals. One example of this is the partnership with the University of Stirling, one of the leading research organisations, based in Scotland.

Professor Randolph Richards, from Stirling said: "Academia is increasingly realising the benefits of working with industry on research projects, and is concentrating on those with more direct impact rather than on pure research. In our own case, Zoetis has been able to provide resources which were otherwise unavailable to us, with funding opportunity being provided through the UK Technology Strategy Board."

Ceva Animal Health has launched a competition - open to veterinary surgeons and nurses - to support Cardalis (benazepril and spironolactone), its dual-acting treatment for heart failure in dogs.

To enter the competition, which will run till the end of April, visit www.cardaliscompetition.co.uk and answer 4 questions about Cardalis. There's a £400 Amazon gift voucher up for grabs.

Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "Cardalis is proving extremely popular and we are therefore very excited to offer veterinary professionals the chance to win a great prize by sharing their knowledge of the product."